RVL Pharmaceuticals Says On October 12, Co Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
Portfolio Pulse from Benzinga Newsdesk
RVL Pharmaceuticals has received a delisting notice from the Listing Qualifications Department of Nasdaq Stock Market LLC on October 12.

October 13, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RVL Pharmaceuticals has received a delisting notice from Nasdaq, which could potentially lead to its stock being removed from the exchange.
Receiving a delisting notice from Nasdaq is a serious matter for any company. It means that the company has failed to meet certain listing requirements, which could be related to its financial health, governance, or other factors. If the company is unable to rectify the situation, its stock could be removed from the exchange, which would likely lead to a significant drop in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100